Myrexis, Inc. (MYRX) es una empresa que cotiza en bolsa en el Servicios Financieros sector, operando dentro de la Shell Companies industria. La empresa tiene su sede en New York City, NY, United States. El CEO actual es Jonathan Couchman.
MYRX tiene fecha de IPO 2009-06-12, 1 empleados a tiempo completo, cotiza en el Other OTC, una capitalización de mercado de $20.69K.
Myrexis, Inc. focuses on identifying, evaluating, and making financial investments in life sciences assets. The company was formerly known as Myriad Pharmaceuticals, Inc. and changed its name to Myrexis, Inc. in July 2010. Myrexis, Inc. is headquartered in New York, New York.
